1.Allen, D., Lee, R. H., & Lowson, K.The use of QALYs in health service planning. International Journal of Health Planning and Management, 1989, 4, 261–73.
2.Barry, M. J., Mulley, A. G., Fowler, F. J., & Wennberg, J. W.Watchful waiting vs. immediate transurethral resection for symptomatic prostatism. The importance of patients’ preferences. Journal of the American Medical Association, 1988, 259, 3010–17.
3.Binkin, N. J., & Koplan, J. P.The high cost and low efficacy of weekly viral cultures for pregnant women with recurrent genital herpes: A reappraisal. Medical Decision Making, 1989, 9, 225–30.
4.Carr-Hill, R. A.Assumptions of the QALY procedure. Social Science and Medicine, 1989, 29, 469–77.
5.Dixon, J., & Welch, H. G.Priority setting: Lessons from Oregon. Lancet, 1991, 337, 891–93.
6.Drummond, M. F.Output measurement for resource allocation decisions in health care. Oxford Review of Economic Policy, 1991, 5, 59–74.
7.Eckman, M. H., Beshansky, J. R., Durand-Zaleski, I., et al. Anticoagulation for noncardiac procedures in patients with prosthetic heart valves. Journal of the American Medical Association, 1990, 263, 1513–1521.
8.Fanshel, S., & Bush, J. W.A health status index and its application to health service outcomes. Operations Research, 1970, 18, 1021–66.
9.Froberg, D. G., & Kane, R. L.Methodology for measuring health-state preferences-II: Scaling methods. Journal of Clinical Epidemiology, 1989, 42, 459–71.
10.Gafni, A., & Zylak, C. J. Ionic vs. non-ionic contrast media: A burden or a bargain. Working paper no. 90–8. Hamilton, Ontario: McMaster University, Centre for Health Economics and Policy Analysis, 1990.
11.Goel, V., Deber, R B., & Detsky, A. S.Nonionic contrast media: Economic analysis and health policy development. Canadian Medical Association Journal, 1989, 140, 389–95.
12.Hadorn, D. C.Setting health care priorities in Oregon. Journal of the American Medical Association, 1991, 265, 2218–25.
13.Hatziandreu, E., Koplan, J. P., Weinstein, M. C., et al. A cost-effectiveness analysis of exercise as a health promotion activity. American Journal of Public Health, 1988, 78,1417–21.
14.Hurley, S.A review of cost-effectiveness analyses. The Medical Journal of Australia, 1990, 153(suppl.), S20–S23.
15.Jønsson, B., Horisberger, B., Bruguera, M., & Matter, L.Cost-benefit analysis of hepatitis-B vaccination. A computerized decision model for Spain. International Journal of Technology Assessment in Health Care, 1991, 7, 379–402.
16.Kaplan, R. M., & Anderson, J. P.A general health policy model: Update and applications. Health Services Research, 1988, 23, 203–35.
17.Kawachi, I., & Malcolm, L. A.The benefits of treating mild to moderate hypertension. Journal of Clinical Epidemiology, 1989, 42, 905–12.
18.Kievit, J., & van de Velde, C. J. H.Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. Cancer, 1990, 65, 2580-87.
19.Loomes, G., & McKenzie, L.The use of QALYs in health care decision making. Social Science and Medicine, 1989, 28, 299–308.
20.Mulkay, M., Ashmore, M., & Pinch, T.Measuring the quality of life: A sociological invention concerning the application of economics to health care. Sociology, 1987, 21, 541–64.
21.Nord, E.Methods for quality adjustment of life years. Social Science & Medicine, 1992, 34, 559–69.
22.Nord, E.The validity of a visual analogue scale in determining social utility weights for health states. International Journal ofHealth Planning and Management, 1991,6,234–42.
23.Nord, E. The use of EuroQol values in QALY calculations. In Björk, (ed), EuroQol Conference Proceedings. IHE Working Paper, 1992:2. Lund, 1992.
24.Nord, E. Unjustified use of the Quality of Well-being Scale in priority setting in Oregon. Health Policy (in press).
25.O'Kelly, T. J., & Westaby, S.Trauma centres and the efficient use of financial resources. British Journal of Surgery, 1990, 77, 1142–44.
26.Pliskin, J. S., Shephard, D. S., & Weinstein, M. C.Utility functions for life years and health status. Operations Research, 1980, 28, 206–22.
27.Rawls, J.A theory of justice. Cambridge, MA: Harvard University Press, 1971.
28.Read, J. L., Quinn, R. J., Berwick, D. M., et al. Preferences for health outcomes. Comparison of assessment methods. Medical Decision Making, 1984, 4, 315–29.
29.Russel, J. G. B.Is screening for abdominal aortic aneurism worthwhile? Clinical Radiology, 1990, 41, 182–84.
30.Schechter, C. B., Rose, D. N., Fahs, M. C, & Silver, A. L.Tuberculin screening: Costeffectiveness analysis of various testing schedules. American Journal of Preventive Medicine, 1990, 6, 167–75.
31.Shephard, R. J.The economics of fitness. Champaign, IL: Human Kinetics, 1986.
32.Shephard, R. J., & Montelpare, W.Geriatric benefits of exercise as an adult. Journal of Gerontology, 1988, 43, M86–90.
33.Smith, A.Qualms about QALYs. Lancet, 1987, i 1134–36.
34.Smith, G. T.The economics of hypertension and stroke. American Heart Journal, 1990, 119, 725–28.
35.Torrance, G. W.Measurement of health state utilities for economic appraisal. Journal of Health Economics, 1986, 5, 1–30.
36.Torrance, G. W.Utility approach to measuring health-related quality of life. Journal of Chronic Diseases, 1987, 40, 593–600.
37.Tsevat, J., Durand-Zalesky, I., & Pauker, S. G.Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints. American Journal of Public Health, 1989, 79, 739–43.
38.Vermeer, F., et al. Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. British Heart Journal, 1988, 59, 527–34.
39.Weinstein, M. C.Economic assessments of medical practices and technologies. Medical Decision Making, 1981, 1, 309–30.
40.Weinstein, M. C., Coley, C. M., & Richter, J. M.Medical management of gallstones: A cost effectiveness analysis. Journal of General Internal Medicine, 1990, 5, 277–84.
41.Weinstein, M. C., & Stason, W. B.Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine, 1976, 296, 716–21.
42.Weinstein, M. C., & Stason, W. B.Cost-effectiveness of coronary artery bypass surgery. Circulation, 1982, 66(suppl. Ill), III–56–III–67.
43.Weinstein, M. C., & Stason, W. B.Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annual Review of Public Health, 1985, 6, 41–63.
44.Williams, A.Economics of coronary artery bypass grafting. British Medical Journal, 1985, 291, 326–29.
45.Williams, A.Who is to live? A question for the economist or the doctor? World Hospitals, 1987, 13, 34–36.
46.Williams, A.The measurement and valuation of improvements in health. In Centre for Health Economics, Newsletter 3. York: University of York, 1988.
47.Wong, J. B., Sonnenberg, F. A., Salem, D. N., & Pauker, S. G.Myocardial revascularization for chronic stable angina. Annals of Internal Medicine, 1990, 113, 852–71.
48.Yates, J. W., Chalmer, B., & McKegney, E. P.Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer, 1980, 45, 2220–24.